Hangzhou innogate pharma
Web2 articles for Hangzhou Innogate Pharma Co., Ltd. The following articles (labelled with PubMed ID or TBD) are for your review; PMID Article Title Published Deposition; … WebDec 13, 2016 - Hangzhou Innogate Pharma Co., Ltd. The present invention provides compounds of Formula (I), and the pharmaceutically acceptable salts, hydrates, and …
Hangzhou innogate pharma
Did you know?
WebHangzhou Innogate Pharma Co., Ltd. US Patent. Ligand BDBM408630 (4-(2-(6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-h...) Show SMILES. Show InChI. Affinity Data IC50: 100nM Assay Description: In vitro IDO1 enzymatic activity was determined in a mixture of 50 mM MES buffer at pH 6.5; 200 nM human IDO enzyme, 150 μM L ... WebSep 7, 2024 · College of Material, Chemistry and Chemical Engineering, Hangzhou Normal University Hangzhou Zhejiang 311121 PR China. ORCIDs linked to this article. Ye Y, 0000-0001-5279-8104, Shanghai University; Li S, 0000-0003-1480-9292, Hangzhou Normal University; Ye XY, 0000-0003-3739-0930, Hangzhou Innogate Pharma Co. Ltd. …
WebHANGZHOU INNOGATE PHARMA CO LTD has a total of 39 patent applications. It decreased the IP activity by 77.0%. Its first patent ever was published in 2016. It filed its … WebOther pharma companies with tricyclic IDO1 inhibitors in their pipeline at present are Hangzhou Innogate Pharma Co., Ltd. [88], Shanghai De Novo Pharmatech Co., Ltd. [89,90] and Redx Pharma plc [91,92]. In summary, the modification mainly focus on the replacements of the benzene motif by 5- or 6- membered heteroaryl groups to fill pocket …
WebHangzhou Normal University: Hangzhou, Zhejiang, CN . 2024-12-01 to present Professor ... Source: Xiang-Yang Ye Hangzhou Innogate Pharma Co. Ltd.: Hangzhou, Zhejiang, CN . 2024-01-01 to present. Employment Show more detail. Source: Xiang-Yang Ye Bristol-Myers Squibb: Princeton, NJ, US . 2002-09-01 to 2016 ... WebFeb 15, 2024 · Hangzhou Innogate Pharma Co. Ltd. has identified kinesin-like protein KIF18A inhibitors reported to be useful for the treatment of cancer and viral infections. All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website.
WebJan 18, 2024 · Hangzhou Innogate Pharma describes new KIF18A inhibitors Jan. 18, 2024 Hangzhou Innogate Pharma Co. Ltd. has identified kinesin-like protein KIF18A …
WebHangzhou Innogate Pharma Co Ltd Original Assignee Hangzhou Innogate Pharma Co Ltd Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2015-04-12 Filing date 2016-04-12 Publication date 2024-10-24 st peter\u0027s in thanetWebJun 7, 2024 · Assigned to Hangzhou Innogate Pharma Co., Ltd., Zhejiang (CN) Filed by Hangzhou Innogate Pharma Co., Ltd., Zhejiang (CN) PCT Filed May 27, 2024, PCT … rothesay kentWebHANGZHOU INNOGATE PHARMA CO LTD has a total of 39 patent applications. It decreased the IP activity by 77.0%. Its first patent ever was published in 2016. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and … rothesay laser clinicWebJan 4, 2024 · BRIEF-CSPC Pharmaceutical Group Unit Entered Agreement With Hangzhou Innogate Pharma January 4, 2024, 4:26 AM Jan 4 (Reuters) - CSPC … rothesay life annuityWebOct 31, 2024 · Hangzhou Innogate Pharma Co. Ltd. has synthesized GTPase KRAS (Gly12Asp mutant) inhibitors reported to be useful for the treatment of cancer. … st peter\u0027s in rome italyWebOther pharma companies with tricyclic IDO1 inhibitors in their pipeline at present are Hangzhou Innogate Pharma Co., Ltd. [88], Shanghai De Novo Pharmatech Co., Ltd. … st peter\u0027s in thanet schoolWeb( 73 ) Assignee : Hangzhou Innogate Pharma Co. , Ltd. , Zhejiang ( CN ) CN CN CN WO 1433417 A 101001857 A 105294736 A ... rothesay life address